Login
$VRTX
$515.14 -$2.35 (0.45%) Live

Ownership

13F as of Q2 2026 · 253.5M shares outstanding

Who owns VRTX?

By type of holder
Institutions 95.1% Insiders 0.2% Everyone else 4.6%
Concentration Top 10 holders own 50.6%
Capital World Investors 10.3% · BlackRock, Inc. 9.5%
Institutional ownership
95.1%
+1.3 pts vs last qtr
Institutional holders
1,746
+60 vs last qtr
Net shares bought
+3.4M
by institutions in Q2 2026
New / sold out
196 / 136
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Norges Bank NEW +3.0M
  • Franklin Resources Inc +2.8M

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Janus Henderson Group PLC SOLD OUT −2.1M
  • Capital Research Global Investors −1.6M

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$158M
57 notices from 14 people
Shares covered
345.4K
0.14% of the company
Arranged in advance
98%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$31.2M$62.5MNov 2025: $32.9M under a 10b5-1 planNov 2025: $341.1K without a planNovDec 2025: $36.2M under a 10b5-1 planDecJan 2026: $6.5M under a 10b5-1 planJanFeb 2026: $62.5M under a 10b5-1 planFebMar 2026: $5.1M under a 10b5-1 planMarApr 2026: $439.3K under a 10b5-1 planAprMay 2026: $5.3M under a 10b5-1 planMay 2026: $2.2M without a planMayJun 2026: $3.7M under a 10b5-1 planJunJul 2026: $2.0M under a 10b5-1 planJulAug 2026: $662.5K without a planAugSepOct
Largest proposed sellers
  • Jeffrey M Leiden Director 10b5-1 $59.5M
  • Sachdev Amit Officer 10b5-1 $28.4M

Sign up to see all 5.

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2016–FY2025
+5.4%
+0.59% a year
Each share's claim on the business
−5.2%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
$6.12B vs $4.55B
over 10 fiscal years
Diluted shares, split-adjusted
237.3M251.7M266.0M2016: 244.7M shares'162017: 253.2M shares'172018: 259.2M shares'182019: 260.7M shares'192020: 263.4M shares'202021: 259.9M shares'212022: 259.1M shares'222023: 260.5M shares'232024: 257.9M shares'242025: 258.0M shares'25
Buybacks Stock-based comp
$0$1.01B$2.02B2016 buybacks: $02016 stock comp: $240.6M'162017 buybacks: $02017 stock comp: $293.2M'172018 buybacks: $350.0M2018 stock comp: $325.0M'182019 buybacks: $186.0M2019 stock comp: $360.5M'192020 buybacks: $539.1M2020 stock comp: $429.5M'202021 buybacks: $1.43B2021 stock comp: $441.4M'212022 buybacks: $02022 stock comp: $491.3M'222023 buybacks: $427.6M2023 stock comp: $581.2M'232024 buybacks: $1.18B2024 stock comp: $698.5M'242025 buybacks: $2.02B2025 stock comp: $685.9M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years80% 3–5 years10% 1–3 years6% Under 1 year4%
Quarterly turnover
6.0%
of institutional shares changed hands
Top 10 managers, median time held
5 years

Super Investors

Investment managers reporting VRTX on Form 13F
CW
Capital World Investors
Shares
26.1M
% of company
10.30%
Change vs last qtr
+746.9K (+2.9%)
Held since
≤2021
B
BlackRock, Inc.
Shares
24.1M
% of company
9.51%
Change vs last qtr
+139.9K (+0.6%)
Held since
≤2021

28 more super investors behind a free account

See every manager holding Vertex Pharmaceuticals Incorporated, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting VRTX on Form N-PORT; together they hold 47.7% of the company
GF
Growth Fund of America
Position value
$5.59B
% of company
4.93%
% of the fund
1.55%
As of
May 31, 2026
VT
Position value
$4B
% of company
3.18%
% of the fund
0.17%
As of
June 30, 2026

23 more funds behind a free account

See every fund holding Vertex Pharmaceuticals Incorporated and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
KR
Kewalramani Reshma
Insider
Shares
98.3K
% of company
0.04%
Change vs last qtr
—
Held since
—
SA
Sachdev Amit
Insider
Shares
96.3K
% of company
0.04%
Change vs last qtr
—
Held since
—

22 more holders behind a free account

See every insider and 5%+ holder of Vertex Pharmaceuticals Incorporated.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support